Indatuximab ravtansine Uses, Dosage, Side Effects and more
Indatuximab ravtansine is under investigation in clinical trial NCT01001442 (Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma).
| Trade Name | Indatuximab ravtansine |
| Generic | Indatuximab ravtansine |
| Indatuximab ravtansine Other Names | Indatuximab ravtansine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
